Zarminali Pediatrics, a new pediatric provider building integrated primary and specialty care, has clinched a $110 million series A funding round.
The latest funding brings the company’s total raised to date to $150 million. Healthier Capital led the round, along with participation from General Catalyst, K2 HealthVentures and Children’s Medical Center Corporation, a nonprofit investing entity affiliated with Boston Children's Hospital.
Amir Dan Rubin, CEO and founding managing partner of Healthier Capital, is joining Zarminali’s board of directors. Rubin is the former CEO of Amazon One Medical.
The new capital will be used to accelerate the rollout of Zarminali’s proprietary tech platform, enter new markets and open de novo clinics.
The Zarminali approach is to have a singularly branded national multispecialty practice, one with clinics that are co-located with urgent care centers and that directly employ both pediatricians and specialists.
“Zarminali is building the digital, operational, and clinical infrastructure for what modern pediatric care should look like in the U.S.,” Holly Maloney, managing director and head of health assurance at General Catalyst, said in a press release. Maloney is also an existing Zarminali board member. “The team has consistently outperformed expectations, and we believe they have the potential to build the first truly scaled, sustainable pediatric health system in the country, which is why we remain committed to investing in the company.”
Since its founding in 2024, Zarminali has been focused on aggressive footprint growth. It does so through a combined strategy of opening de novo clinics and acquiring established practice groups (nine acquired in 2025). Zarminali currently has 28 clinics in eight states. In 2026, the startup plans to be equally or more acquisitive and also open 15 de novo clinics, including in new markets like Chicago, Milwaukee and Dallas. Zarminali delivered over 100,000 patient visits in 2025.
“Our entire goal is to be able to say, 'Anything and everything that is related to your child that can happen outside of the hospital, we want to be able to deliver that under one umbrella,'” Zarminali Founder and CEO Danish Qureshi told Fierce Healthcare. The aim is to be among the top 30 states by population in the next two years.
Qureshi experienced the challenge of navigating the choppy healthcare system after his daughter was diagnosed with an autoimmune disorder, where there was a serious lack of coordination between pediatricians and specialists. The need for strong care has arguably never been greater. The physical, mental and developmental health of American children has gotten significantly worse across a broad spectrum of indicators over the past 16 years, per a recent JAMA study cited in the Zarminali press release. Zarminali aims to provide a modern pediatric experience that seamlessly coordinates care across the full care continuum.
Boston Children's will also act as a close collaborator to Zarminali as the company looks to expand its footprint in Massachusetts and pursue more health system partnerships nationwide.
“Though we want to be, from a community perspective, offering as much as possible, there is also an acknowledgment that what we ultimately care about is getting the best possible care for our patients," Qureshi said. "And that means working with health systems to be able to send them referrals and remain in close communication."
Zarminali accepts a number of commercial insurance plans. It hopes to establish value-based partnerships with payers in the future and has begun hiring people with that background to begin conversations with Medicaid managed plans, per Qureshi. “We’re not rushing to managed Medicaid and value-based care, but we’re also not blind to it, and starting to make those early investments now,” Qureshi said.
Regardless of what types of outcomes payers may want to see, Qureshi acknowledged that tracking outcomes is the right thing to do for high-quality care. Zarminali is currently building out its analytics platform with the hopes of creating a nationwide scorecard for Zarminali clinicians to see how they’re doing on quality metrics. While that will serve as the foundation for value-based work in the future anyway, “we believe tracking those outcomes is the right thing to do for patients no matter what,” Qureshi said.
The startup eventually plans to expand its specialty services to include speech therapy, occupational therapy and behavioral health services. Urgent cares with extended hours will also be co-located in select locations. By the end of 2026, Zarminali hopes to offer 24/7 telehealth for primary care needs with the goal of expanding to other care in the future.
Zarminali has an in-house hiring team but is also getting inbounds of candidates through word-of-mouth referrals. “What we’re trying to build here is essentially what many of them have always hoped for,” Zarminali said of doctors interested in the company. In residency, “you’re not training in a silo of just your narrow type of clinician. You’re actually training in a team setting, there’s a lot of collaboration.”
Editor's Note: After this story was published, Zarminali clarified that the investing entity is Children’s Medical Center Corporation, not Boston Children's Hospital itself. This story was updated on Jan. 26 to reflect that.